Metabolic Characteristics of Spleen-Qi Deficiency Syndrome in Ulcerative Colitis
-
摘要: 目的 基于非靶标代谢组学探索溃疡性结肠炎(UC)脾气虚证的生物学基础。方法 采用液相色谱质谱联用方法对UC脾气虚证和湿热证患者血清进行代谢组学分析。结果 UC脾气虚证存在脂质代谢紊乱, 与UC湿热证患者比较, UC脾气虚证血清中1-油酰基甘油磷酸胆碱、溶血磷脂、鞘氨醇、N-棕榈酰磷酸乙醇胺、棕榈酰肉碱、O-花生四烯酰缩水甘油等代谢产物丰度降低, 2-亚油酰甘油丰度升高。ROC曲线结果显示, O-花生四烯酰缩水甘油、棕榈酰胺、2-亚油酰甘油可能是诊断UC脾气虚证的潜在生物标志物。结论 代谢组学方法有望揭示UC中医证候的生物学本质, 为UC中医辨证提供一定客观依据。Abstract: OBJECTIVE To explore the biological basis of spleen-qi deficiency syndrome of ulcerative colitis based on non-target metabolomics.METHODS The UC patients with spleen-qi deficiency syndrome and damp-heat syndrome were analyzed by metabolomics by LC-MS.RESULTS There were lipid metabolism disorders in UC patients with spleen-qi deficiency. Compared with UC patients with damp-heat, the average abundance of 1-linoleoylglycerophosphocholine, lysophospholipid, sphingosine, N-palmitoyl-phosphoethanolamine, palmitoylcarnitine and O-arachidonoyl glycidol decreased in the UC patients with spleen-qi deficiency, while the average abundance of 2-linoleoyl glycerol increased. ROC curve showed that O-arachidonoyl glycidol, palmitic amide and 2-linoleoyl glycerol may be potential biomarkers of spleen-qi deficiency syndrome in UC.CONCLUSION Metabolomics is expected to reveal the biological nature of TCM syndromes in UC.
-
Key words:
- ulcerative colitis /
- spleen-qi deficiency /
- metabolomics
-
表 1 2组基线资料比较(x±s)
组别 性别 年龄/岁 BMI 男 女 健康对照组(n=27) 8 19 44.3±10.91 21.35±2.91 UC湿热证组(n=30) 17 13 42.13±12.41 23.11±3.34 UC脾气虚证组(n=31) 18 13 38.77±8.50 20.48±3.96 表 2 疾病特征
组别 病程/ a 直肠型 左半结肠型 广泛结肠型 血沉/ (mm·h-1) C反应蛋白/ (mg·L-1) 粪钙卫蛋白/ (μg·g-1) UC湿热证(n=30) 5.00±0.93 4 10 16 26.52±5.36 18.88±5.92 671.84±125.65 UC脾气虚证(n=31) 4.62±0.72 2 9 20 21.52±4.20 7.52±2.43 439.2±70.60 -
[1] RUBIN DT, ANANTHAKRISHNAN AN, SIEGEL CA, et al. ACG clinical guideline: Ulcerative colitis in adults[J]. Am J Gastroenterol, 2019, 114(3): 384-413. doi: 10.14309/ajg.0000000000000152 [2] 贾海忠. 论自然态基本证候分类是中医发展的突破口[J]. 中医杂志, 2011, 52(17): 1441-1443. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ201117004.htm [3] SCOVILLE EA, ALLAMAN MM, BROWN CT, et al. Alterations in lipid, amino acid, and energy metabolism distinguish Crohn's disease from ulcerative colitis and control subjects by serum metabolomic profiling[J]. Metabolomics, 2017, 14(1): 1-12. [4] 刘毅, 冯晓桃, 王文健. "脾主运化"理论再认识: "脾主运"与"脾主化"之辨析[J]. 中医杂志, 2011, 52(15): 1264-1266. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ201115005.htm [5] 吴开春, 梁洁, 冉志华, 等. 炎症性肠病诊断与治疗的共识意见[J]. 中国实用内科杂志, 2018, 38(9): 796-813. https://www.cnki.com.cn/Article/CJFDTOTAL-SYNK201809007.htm [6] 国家中医药管理局. 中医病证诊断疗效标准[M]. 中医病证诊断疗效标准, 1994. [7] 中华中医药学会. 中医内科常见病诊疗指南: 中医病症部分[M]. 北京: 中国中医药出版社, 2008. [8] 张声生, 沈洪, 郑凯, 等. 溃疡性结肠炎中医诊疗专家共识意见(2017)[J]. 中华中医药杂志, 2017, 32(8): 3585-3589. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201708071.htm [9] HU J, HUANG H, CHE Y, et al. Qingchang Huashi Formula attenuates DSS-induced colitis in mice by restoring gut microbiota-metabolism homeostasis and goblet cell function[J]. J Ethnopharmacol, 2021, 266: 113394. doi: 10.1016/j.jep.2020.113394 [10] 刘刚. 苦参碱治疗胆汁淤积性肝炎药理与临床研究[J]. 中西医结合肝病杂志, 2005, 15: 311-313. doi: 10.3969/j.issn.1005-0264.2005.05.031 [11] 朱玲. Ⅰ型超敏反应的细胞分子机制及其抗炎蛋白质的研究[D]. 苏州: 苏州大学, 2003. [12] LIN H, ZHANG J, GAO P. Silent myocardial ischemia is associated with altered plasma phospholipids[J]. J Clin Lab Anal, 2009, 23(1): 45-50. doi: 10.1002/jcla.20288 [13] NALECZ KA, MIECZ D, BEREZOWSKI V, et al. Carnitine: Transport and physiological functions in the brain[J]. Mol Aspects Med, 2004, 25(5/6): 551-567. http://www.onacademic.com/detail/journal_1000035417278210_e4d9.html [14] CHEN Y, QIU X, YANG J. Comparing the in vitro antitumor, antioxidant and anti-inflammatory activities between two new very long chain polyunsaturated fatty acids, docosadienoic acid(DDA)and docosatrienoic acid(DTA), and docosahexaenoic acid(DHA)[J]. Nutr Cancer, 2021, 73(9): 1697-1707. doi: 10.1080/01635581.2020.1804949 [15] PARK YH, SHI YP, LIANG B, et al. High-resolution metabolomics to discover potential parasite-specific biomarkers in a Plasmodium falciparum erythrocytic stage culture system[J]. Malar J, 2015, 14: 122. doi: 10.1186/s12936-015-0651-1 [16] SHAMRAN H, SINGH NP, ZUMBRUN EE, et al. Fatty acid amide hydrolase(FAAH)blockade ameliorates experimental colitis by altering microRNA expression and suppressing inflammation[J]. Brain Behav Immun, 2017, 59: 10-20. doi: 10.1016/j.bbi.2016.06.008 [17] STORR MA, KEENAN CM, EMMERDINGER D, et al. Targeting endocannabinoid degradation protects against experimental colitis in mice: Involvement of CB1 and CB2 receptors[J]. J Mol Med, 2008, 86(8): 925-936. doi: 10.1007/s00109-008-0359-6 [18] GIL-ORDONEZ A, MARTIN-FONTECHA M, ORTEGA-GUTIERREZ S, et al. Monoacylglycerol lipase(MAGL)as a promising therapeutic target[J]. Biochem Pharmacol, 2018, 157: 18-32. doi: 10.1016/j.bcp.2018.07.036 [19] YUAN D, WU Z, WANG Y. Evolution of the diacylglycerol lipases[J]. Prog Lipid Res, 2016, 64: 85-97. doi: 10.1016/j.plipres.2016.08.004 [20] EZZILI C, OTRUBOVA K, BOGER DL. Fatty acid amide signaling molecules[J]. Bioorg Med Chem Lett, 2010, 20(20): 5959-5968. doi: 10.1016/j.bmcl.2010.08.048